June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Results of surgical treatment in uveitic glaucoma refractory to medical treatment
Author Affiliations & Notes
  • Lidia Cocho
    IOBA (Institute of Applied OphthalmoBiology), Universidad de Valladolid, Valladolid, Castilla y León, Spain
    Department of ophthalmology, Valladolid Clinical Hospital, Valladolid, Valladolid, Spain
  • Florencia Cellini
    IOBA (Institute of Applied OphthalmoBiology), Universidad de Valladolid, Valladolid, Castilla y León, Spain
  • J. Ramon Juberías
    IOBA (Institute of Applied OphthalmoBiology), Universidad de Valladolid, Valladolid, Castilla y León, Spain
    Department of ophthalmology, Valladolid Clinical Hospital, Valladolid, Valladolid, Spain
  • Jose M. Herreras
    IOBA (Institute of Applied OphthalmoBiology), Universidad de Valladolid, Valladolid, Castilla y León, Spain
    Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain
  • Margarita Calonge
    IOBA (Institute of Applied OphthalmoBiology), Universidad de Valladolid, Valladolid, Castilla y León, Spain
    Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain
  • Footnotes
    Commercial Relationships   Lidia Cocho None; Florencia Cellini None; J. Ramon Juberías None; Jose M. Herreras None; Margarita Calonge None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3570. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lidia Cocho, Florencia Cellini, J. Ramon Juberías, Jose M. Herreras, Margarita Calonge; Results of surgical treatment in uveitic glaucoma refractory to medical treatment. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3570.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To analyze the results and long-term efficacy of surgical treatment in patients with uveitic glaucoma (UG) refractory to maximum medical treatment.

Methods : Retrospective observational study by reviewing the medical records of patients with a diagnosis of GU refractory to maximum medical treatment who underwent surgery in the Glaucoma Unit at Valladolid Clinical Hospital and Institute of Applied OphthalmoBiology (IOBA) in the last 10 years.

Results : A total of 26 patients and 30 eyes were studied. The average age of the patients was 60.07±14.38 years. Sex distribution was 17 men and 9 women. Complete success (IOP <21 mmHg without additional medical treatment) 1 year (n = 26) after surgery was achieved in 16 (61.5%) cases, and partial success (IOP <21 mmHg with additional medical treatment) was achieved in 10 cases (38.4%), while complete and partial success had a distribution of 50% respectively after 4 years (n = 14) at follow up. The surgical techniques performed were DDG with Ahmed valve implant in 25 (83.3%) cases, EPNP with MMC in three cases (10%), and TB with MMC in two cases (6.7%). The preoperative mean IOP was 31.7±9.2 (range, 16 - 52) mmHg, and the postoperative mean IOP after 1 year was 14.6±4.2 mmHg (53.95% reduction), and the IOP after 4 years was 14.0±3.8 mmHg (55.83% reduction). The mean preoperative antiglaucoma BP used was 3.5±0.8 (2 – 5 range), a mean decrease of 3.2 1 year after surgery and 2.6 4 years after surgery. These values were statistically significant (p <0.001) in all cases.

Conclusions : Surgical treatment can control intraocular pressure in the medium and long term in patients with UG refractory to medical treatment. In up to 50% of the cases a topical hypotensive treatment might be required in addition to surgical treatment to achieve the target IOP.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×